Synthes, Globus call truce on trade secrets dispute
This article was originally published in Clinica
Swiss spinal implant developer Synthes, which has its US headquarters based in West Chester, Pennsylvania, is to gain $13.5m from rival Globus Medical to settle a row over the alledged theft of trade secrets as well as violations of non-compete and confidentiality agreements. Under the terms of the settlement, Audubon, Pennsylvania-based Globus, which continues to maintain it has not taken any trade secrets, also agreed to not solicit or hire Synthes employees for one year until August 10 2008. In return, Synthes has dropped all six lawsuits filed against Globus.
You may also be interested in...
FTC pursuing bogus health and other products or services capitalizing on Covid-19 fear with scams skyrocketing. However, FTC says its enforcement will consider whether businesses are making good faith efforts to produce products in high demand.
Warning letters show FDA's coronavirus investigations inthe consumer health marketplace didn't stop when it suspended facility inspections. The letters identify firms that previously marketed only bedding products as offering supplements with coronavirus claims or that are in other countries and are shipping to US consumers products promoted with coronavirus claims.
The coronavirus pandemic has thrown up unprecedented challenges for the Indian clinical trials segment, as in other parts of the world. Experts tell Scrip how things are poised in the country including potential impact on some critical milestones, but efforts are underway to tackle the crisis.